FDA Approved: OLANZAPINE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved Sandoz Inc.'s supplemental application for olanzapine (ANDA201588). This action updates the approval for the generic product, potentially affecting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• olanzapine (olanzapine)

Snippet

SUPPL AP for OLANZAPINE (OLANZAPINE)